Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[EGFR-mutation in non-small cell lung carcinoma. Treatment with tyrosine kinase inhibitors possible].

Nederlands tijdschrift voor geneeskunde - 1 Jan 2011

Thunnissen Erik, Smit Egbert F, Nederlof Petra M, Dingemans Anne-Marie C

Abstract excerpt

Non-small cell lung carcinomas (NSCLCs) in which there is a mutation of the epidermal growth factor receptor (EGFR) constitute a separate group of lung carcinomas. They occur more often in women, non-smokers and Asian people, take the form of adenocarcinoma and their prognosis is better. For a number of years, oral tyrosine kinase inhibitors (TKI's) have been registered for the treatment of lung cancer. Response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Share to Protein Kinase Inhibitors

Share to Protein-Tyrosine Kinases

Share to Sex Factors

Source

Identifiers

PMID: 21418699

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[EGFR-mutation in non-small cell lung carcinoma. Treatment with tyrosine kinase inhibitors possible].PMID 21418699Read ↗

[Inhibitors of the EGFR pathway in non small cell lung cancer: what's new in 2007?].Semantic proximity Read ↗

[Clinical and molecular predictors of response to EGFR tyrosine kinase inhibitors in non-small cell lung cancer].Semantic proximity Read ↗

[Indication of EGFR kinase inhibitors should be refined].Semantic proximity Read ↗

[Epidermal growth factor receptor mutations and radiotherapy in non-small cell lung cancer].Semantic proximity Read ↗

[High resolution melting analysis for detecting p53 gene mutations in patients with non-small cell lung cancer].Semantic proximity Read ↗

Antitumoral activity of tyrosine kinase inhibitors in patients with non-small cell lung cancer harbouring rare epidermal growth factor receptor mutations.Semantic proximity Read ↗

[Epidermal growth factor receptor (EGFR): therapeutic target in the treatment of lung adenocarcinoma].Semantic proximity Read ↗

[Epidermal growth factor receptor gene mutations, amplification and clinicopathologic correlation in patients with lung cancer].Semantic proximity Read ↗

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].Semantic proximity Read ↗

[K-RAS gene mutations in patients with non-small cell lung cancer].Semantic proximity Read ↗

Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism InvestigationSemantic proximity Read ↗

Detection of EGFR mutations in patients with non-small cell lung cancer by high resolution melting. Comparison with other methods.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.